Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Potential pancreatitis treatments reported by Snow Brand

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

5-HT2 antagonists claimed by Toa Eiyo

May 10, 1996

New antihypertensive/diuretic isolated from natural source

May 10, 1996

Endothelin antagonists reported by Bristol-Myers Squibb

May 10, 1996

Ciba-Geigy reveals renin inhibitors

May 10, 1996

E. Merck continues to investigate angiotensin II blockers

May 10, 1996

Daicel reports neuronal cell protectant

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...